skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic hydroxy compound > phenols > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > hydroxides > organic hydroxy compound > phenols > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > s-block molecular entity > hydrogen molecular entity > hydroxides > organic hydroxy compound > phenols > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
organic aromatic compound > phenols > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > organooxygen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > secondary amino compound > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > secondary amino compound > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > primary carboxamide > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
organooxygen compound > carboxamide > primary carboxamide > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > primary carboxamide > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > salicylamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > organooxygen compound > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > salicylamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > monocarboxylic acid amide > arenecarboxamide > benzamides > salicylamides > 2-hydroxy-5-/{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl/}benzamide > (s,r)-labetolol

Preferred term

(s,r)-labetolol  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C19H24N2O3

inchi

  • InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)/t13-,18-/m1/s1

inchikey

  • SGUAFYQXFOLMHL-FZKQIMNGSA-N

mass

  • 328.412

monoisotopicmass

  • 328.17869

smiles

  • C[C@H](CCC1=CC=CC=C1)NC[C@@H](O)C1=CC(C(N)=O)=C(O)C=C1

subset

  • 3_STAR

synonym EXACT

  • 2-hydroxy-5-[(1S)-1-hydroxy-2-{[(2R)-4-phenylbutan-2-yl]amino}ethyl]benzamide

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:167641

Download this concept:

RDF/XML TURTLE JSON-LD